Human KRT10(Keratin 10) ELISA Kit
To Order Contact us: [email protected]
Human Keratin 10 (KRT10) ELISA Kit |
|||
RD-KRT10-Hu-48Tests | Reddot Biotech | 48 Tests | 600 EUR |
Human Keratin 10 (KRT10) ELISA Kit |
|||
RD-KRT10-Hu-96Tests | Reddot Biotech | 96 Tests | 830.4 EUR |
Human Keratin 10 (KRT10) ELISA Kit |
|||
20-abx152104 | Abbexa |
|
|
Human Keratin 10 (KRT10) ELISA Kit |
|||
abx251545-96tests | Abbexa | 96 tests | 848.4 EUR |
Human Keratin 10 (KRT10) ELISA Kit |
|||
abx574505-96tests | Abbexa | 96 tests | 848.4 EUR |
Human Keratin 10 (KRT10) ELISA Kit |
|||
SEB691Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5402.92 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 10 (KRT10) ELISA Kit |
|||
SEB691Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 550.13 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 10 (KRT10) ELISA Kit |
|||
SEB691Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 734.46 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 10 (KRT10) ELISA Kit |
|||
SEB691Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 2945.08 EUR |
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Keratin 10 (KRT10) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Keratin 10 (KRT10) ELISA Kit |
|||
4-SEB691Hu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Keratin 10 (KRT10) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Human Keratin 10 ELISA Kit (KRT10) |
|||
RK01738 | Abclonal | 96 Tests | 625.2 EUR |
Human Keratin 10(KRT10)ELISA Kit |
|||
QY-E02836 | Qayee Biotechnology | 96T | 433.2 EUR |
Cow Keratin 10 (KRT10) ELISA Kit |
|||
abx519988-96tests | Abbexa | 96 tests | 1093.2 EUR |
Dog Keratin 10 (KRT10) ELISA Kit |
|||
abx519989-96tests | Abbexa | 96 tests | 1093.2 EUR |
Mouse Keratin 10 (KRT10) ELISA Kit |
|||
abx519991-96tests | Abbexa | 96 tests | 801.6 EUR |
Rat Keratin 10 (KRT10) ELISA Kit |
|||
abx519992-96tests | Abbexa | 96 tests | 801.6 EUR |
ELISA kit for Human KRT10 (Keratin 10) |
|||
ELK2149 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A sandwich ELISA kit for detection of Keratin 10 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Keratin 10 (KRT10) Antibody |
|||
20-abx100807 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
20-abx100808 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
20-abx123052 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
20-abx113334 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
20-abx013128 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
abx032944-400ul | Abbexa | 400 ul | 627.6 EUR |
Keratin 10 (KRT10) Antibody |
|||
abx032944-80l | Abbexa | 80 µl | 343.2 EUR |
Keratin 10 (KRT10) Antibody |
|||
abx032945-400ul | Abbexa | 400 ul | 627.6 EUR |
Keratin 10 (KRT10) Antibody |
|||
abx032945-80l | Abbexa | 80 µl | 343.2 EUR |
Keratin 10 (KRT10) Antibody |
|||
20-abx210411 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
abx332811-100ul | Abbexa | 100 ul | 510 EUR |
Keratin 10 (KRT10) Antibody |
|||
20-abx329415 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
abx224350-100ug | Abbexa | 100 ug | 493.2 EUR |
Keratin 10 (KRT10) Antibody |
|||
abx224458-100ug | Abbexa | 100 ug | 493.2 EUR |
Keratin 10 (KRT10) Antibody |
|||
20-abx242429 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
abx234648-100ug | Abbexa | 100 ug | 610.8 EUR |
Keratin 10 (KRT10) Antibody |
|||
20-abx211361 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody |
|||
20-abx173242 | Abbexa |
|
|
Recombinant Keratin 10 (KRT10) |
|||
4-RPB691Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Keratin 10 expressed in: E.coli |
|||
Recombinant Keratin 10 (KRT10) |
|||
4-RPB691Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Keratin 10 expressed in: E.coli |
|||
Human Keratin 10 (KRT10) CLIA Kit |
|||
20-abx492996 | Abbexa |
|
|
Human Keratin 10 (KRT10) Protein |
|||
20-abx067604 | Abbexa |
|
|
Rat Keratin 10 (KRT10) Protein |
|||
20-abx067605 | Abbexa |
|
|
Keratin 10 (KRT10) Antibody (Biotin) |
|||
20-abx273364 | Abbexa |
|
|
Keratin 10 (KRT10) Polyclonal Antibody (Human) |
|||
4-PAB691Hu01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10) |
|||
Human KRT10(Keratin, type I cytoskeletal 10) ELISA Kit |
|||
EH2203 | FN Test | 96T | 628.92 EUR |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 9.375pg/ml |
|||
Human KRT10/ Keratin, type I cytoskeletal 10 ELISA Kit |
|||
E1399Hu | Sunlong | 1 Kit | 685.2 EUR |
Human Keratin, type I cytoskeletal 10, KRT10 ELISA KIT |
|||
ELI-07330h | Lifescience Market | 96 Tests | 988.8 EUR |
Human Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|||
YLA4484HU-48T | Shanghai YL Biotech | 48T | 435 EUR |
Human Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|||
YLA4484HU-96T | Shanghai YL Biotech | 96T | 562.5 EUR |
Human Keratin, type I cytoskeletal 10 (KRT10) |
|||
1-CSB-EP012504HU | Cusabio |
|
|
Description: Recombinant Human Keratin, type I cytoskeletal 10(KRT10) expressed in E.coli |
|||
Human KeRatin, type I cytoskeletal 10 (KRT10) |
|||
1-CSB-YP012504HU1 | Cusabio |
|
|
Description: Recombinant Human KeRatin, type I cytoskeletal 10(KRT10),partial expressed in Yeast |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), APC |
|||
4-PAB691Hu01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with APC. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), Biotinylated |
|||
4-PAB691Hu01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with Biotin. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), Cy3 |
|||
4-PAB691Hu01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with Cy3. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), FITC |
|||
4-PAB691Hu01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with FITC. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), HRP |
|||
4-PAB691Hu01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with HRP. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), PE |
|||
4-PAB691Hu01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with PE. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat) |
|||
4-PAB691Ra01 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10) |
|||
ELISA kit for Human Keratin, type I cytoskeletal 10 (KRT10) |
|||
KTE61887-48T | Abbkine | 48T | 398.4 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 10 (KRT10) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Keratin, type I cytoskeletal 10 (KRT10) |
|||
KTE61887-5platesof96wells | Abbkine | 5 plates of 96 wells | 2538 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 10 (KRT10) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human Keratin, type I cytoskeletal 10 (KRT10) |
|||
KTE61887-96T | Abbkine | 96T | 646.8 EUR |
Description: Quantitative sandwich ELISA for measuring Human Keratin, type I cytoskeletal 10 (KRT10) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human KRT10 (Keratin, Type I Cytoskeletal 10) |
|||
E-EL-H2118 | Elabscience Biotech | 1 plate of 96 wells | 640.8 EUR |
Description: A sandwich ELISA kit for quantitative measurement of Human KRT10 (Keratin, Type I Cytoskeletal 10) in samples from Serum, Plasma, Cell supernatant |
|||
Dog KRT10/ Keratin, type I cytoskeletal 10 ELISA Kit |
|||
E0066Do | Sunlong | 1 Kit | 860.4 EUR |
Mouse Keratin, type I cytoskeletal 10, Krt10 ELISA KIT |
|||
ELI-07327m | Lifescience Market | 96 Tests | 1038 EUR |
Bovine Keratin, type I cytoskeletal 10, KRT10 ELISA KIT |
|||
ELI-07328b | Lifescience Market | 96 Tests | 1113.6 EUR |
Rat Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|||
YLA1722RA-48T | Shanghai YL Biotech | 48T | 465 EUR |
Rat Keratin, type I cytoskeletal 10(KRT10)ELISA Kit |
|||
YLA1722RA-96T | Shanghai YL Biotech | 96T | 600 EUR |
Human Keratin, Type I Cytoskeletal 10 (KRT10) CLIA Kit |
|||
abx195422-96tests | Abbexa | 96 tests | 990 EUR |
Keratin 10 antibody |
|||
10-2541 | Fitzgerald | 250 ug | 590.4 EUR |
Description: Mouse monoclonal Keratin 10 antibody |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Human), APC-Cy7 |
|||
4-PAB691Hu01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Human Keratin 10 (KRT10). This antibody is labeled with APC-Cy7. |
|||
Keratin, Type I Cytoskeletal 10 (KRT10) Antibody |
|||
20-abx109953 | Abbexa |
|
|
Keratin 10 (KRT10) Polyclonal Antibody (Rat), APC |
|||
4-PAB691Ra01-APC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with APC. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), Biotinylated |
|||
4-PAB691Ra01-Biotin | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with Biotin. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), Cy3 |
|||
4-PAB691Ra01-Cy3 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with Cy3. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), FITC |
|||
4-PAB691Ra01-FITC | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with FITC. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), HRP |
|||
4-PAB691Ra01-HRP | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with HRP. |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), PE |
|||
4-PAB691Ra01-PE | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with PE. |
|||
CLIA kit for Human KRT10 (Keratin, Type I Cytoskeletal 10) |
|||
E-CL-H1268 | Elabscience Biotech | 1 plate of 96 wells | 700.8 EUR |
Description: A sandwich CLIA kit for quantitative measurement of Human KRT10 (Keratin, Type I Cytoskeletal 10) in samples from Serum, Plasma, Cell supernatant |
|||
Keratin 10 (KRT10) Polyclonal Antibody (Rat), APC-Cy7 |
|||
4-PAB691Ra01-APC-Cy7 | Cloud-Clone |
|
|
Description: A Rabbit polyclonal antibody against Rat Keratin 10 (KRT10). This antibody is labeled with APC-Cy7. |
|||
Keratin 10 Cell ELISA Kit |
|||
abx595336-96tests | Abbexa | 96 tests | 764.4 EUR |
Human Keratin- associated protein 10- 10, KRTAP10-10 ELISA KIT |
|||
ELI-19292h | Lifescience Market | 96 Tests | 988.8 EUR |
KRT10 Antibody / Cytokeratin 10 |
|||
V9057-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V9057-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V9057IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V9057SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2666-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2666-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2666IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2666SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5 kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3181-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3181-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3181IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3181SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3188-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3188-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3188SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3310-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3310-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3310SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3602-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3602-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3602IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3602SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3603-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (KRT10). KRT10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of KRT10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, KRT10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), KRT10 is detected very frequently. Expression is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3603-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (KRT10). KRT10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of KRT10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, KRT10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), KRT10 is detected very frequently. Expression is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3603IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (KRT10). KRT10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of KRT10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, KRT10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), KRT10 is detected very frequently. Expression is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3603SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (KRT10). KRT10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of KRT10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, KRT10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), KRT10 is detected very frequently. Expression is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3632-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3632-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3632IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3632SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3633-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3633-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3633IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3633SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3711-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin-10 (CK-10) or keratin-10 (K10) is a protein that in humans is encoded by the KRT10 gene. CK10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3711-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Cytokeratin-10 (CK-10) or keratin-10 (K10) is a protein that in humans is encoded by the KRT10 gene. CK10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3711IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Cytokeratin-10 (CK-10) or keratin-10 (K10) is a protein that in humans is encoded by the KRT10 gene. CK10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V3711SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Cytokeratin-10 (CK-10) or keratin-10 (K10) is a protein that in humans is encoded by the KRT10 gene. CK10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V7113-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. This gene is located within a cluster of keratin family members on chromosome 17q21. Keratin 10 has been shown to interact with AKT1. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V7113-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. This gene is located within a cluster of keratin family members on chromosome 17q21. Keratin 10 has been shown to interact with AKT1. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V7113IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. This gene is located within a cluster of keratin family members on chromosome 17q21. Keratin 10 has been shown to interact with AKT1. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V7113SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Keratin-10 is a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. This gene is located within a cluster of keratin family members on chromosome 17q21. Keratin 10 has been shown to interact with AKT1. [Wiki] |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2174-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). cytokeratin 10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of cytokeratin 10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, cytokeratin 10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), cytokeratin 10 is detected very frequently. Expression of cytokeratin 10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2174-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This antibody recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). cytokeratin 10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of cytokeratin 10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, cytokeratin 10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), cytokeratin 10 is detected very frequently. Expression of cytokeratin 10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2174IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: This antibody recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). cytokeratin 10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of cytokeratin 10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, cytokeratin 10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), cytokeratin 10 is detected very frequently. Expression of cytokeratin 10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V2174SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This antibody recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). cytokeratin 10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of cytokeratin 10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, cytokeratin 10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), cytokeratin 10 is detected very frequently. Expression of cytokeratin 10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V7915-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This MAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V7915-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This MAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
V7915SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This MAb recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody / Cytokeratin 10 |
|||
RQ5408 | NSJ Bioreagents | 100 ul | 419 EUR |
Krt10/ Rat Krt10 ELISA Kit |
|||
ELI-07331r | Lifescience Market | 96 Tests | 1063.2 EUR |
Human Keratin- associated protein 5- 10, KRTAP5-10 ELISA KIT |
|||
ELI-42734h | Lifescience Market | 96 Tests | 988.8 EUR |
Pesticide Kit Containing All 10 Multi-Compound Mixes |
|||
SPXPR-KIT | Scientific Laboratory Supplies | 1ML | 1923.18 EUR |
KRT10 ELISA KIT|Human |
|||
EF006272 | Lifescience Market | 96 Tests | 826.8 EUR |
Human KRT10 ELISA Kit |
|||
ELA-E2288h | Lifescience Market | 96 Tests | 988.8 EUR |
Keratin 10 antibody |
|||
70R-31259 | Fitzgerald | 100 ug | 392.4 EUR |
Description: Rabbit polyclonal Keratin 10 antibody |
|||
Keratin 10 Antibody |
|||
33422-100ul | SAB | 100ul | 302.4 EUR |
Keratin 10 Antibody |
|||
33422-50ul | SAB | 50ul | 224.4 EUR |
Keratin 10 Antibody |
|||
ABF0197 | Lifescience Market | 100 ug | 525.6 EUR |
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC040844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC040844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC050844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC050844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNCAP0844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNCAP0844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNCB0844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNCB0844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNCP0844-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNCR0844-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), RPE conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC940844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC940844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNCA0844-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), APC conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC810844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC810844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNUB0844-100 | Biotium | 100uL | 250.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), Concentration: 0.2mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNUB0844-500 | Biotium | 500uL | 549.6 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), Concentration: 0.2mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNCH0844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNCH0844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC880844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC880844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC680844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC680844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC470844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC470844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC400844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC400844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC430844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC430844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC550844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC550844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC610844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC610844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC800844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC800844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC700844-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNC700844-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10(KRT10/844) Antibody |
|||
BNUM0844-50 | Biotium | 50uL | 474 EUR |
Description: Primary antibody against Cytokeratin 10(KRT10/844), 1mg/mL |
|||
KRT10 Antibody Cocktail / Cytokeratin 10 |
|||
V3256-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb cocktail recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody Cocktail / Cytokeratin 10 |
|||
V3256-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: This mAb cocktail recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
KRT10 Antibody Cocktail / Cytokeratin 10 |
|||
V3256SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: This mAb cocktail recognizes a protein of 56.5kDa, identified as cytokeratin 10 (CK10). CK10 is expressed in all suprabasal layers of the epidermis. In the epidermis, expression of CK10 strictly parallels the extent of differentiation; it is absent in the basal layer, appears in the first suprabasal layers and increases in concentration towards the granular layer. However, CK10 is rarely detected in early stages of vulvar squamous carcinomas (tumors less than 2 cm, clinical stage I) regardless of the tumor grade. In larger and more advanced tumors (greater than 2 cm, clinical stages II and III), CK10 is detected very frequently. Expression of CK10 is related to maturation of malignant keratinocytes, being preferentially detected in more-differentiated parts. |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC041990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC041990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNCAP1990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNCAP1990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNCH1990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNCH1990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNCP1990-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNCR1990-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), RPE conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC941990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC941990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNCA1990-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), APC conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC811990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC811990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNUB1990-100 | Biotium | 100uL | 316.8 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), Concentration: 0.2mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNUB1990-50 | Biotium | 50uL | 486 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), 1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNUB1990-500 | Biotium | 500uL | 615.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), Concentration: 0.2mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC881990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC881990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNCB1990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNCB1990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC611990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC611990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC681990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC681990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC431990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC431990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC471990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC471990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC401990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC401990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC551990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC551990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC801990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC801990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC051990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC051990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC701990-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R) Antibody |
|||
BNC701990-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Cytokeratin 10 (KRT10) (Suprabasal Epithelial Marker) (KRT10/1990R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Keratin 10 Colorimetric Cell-Based ELISA Kit |
|||
EKC1320 | BosterBio | 100ul | 686.4 EUR |
Mouse Keratin- associated protein 16- 10, Krtap16-10 ELISA KIT |
|||
ELI-19806m | Lifescience Market | 96 Tests | 1038 EUR |
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC041276-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC041276-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF405S conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNCAP1276-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNCAP1276-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNCP1276-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),PerCP conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNCR1276-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),RPE conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC941276-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC941276-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF594 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNCA1276-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),APC conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC811276-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC811276-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF680R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNUB1276-100 | Biotium | 100uL | 250.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275), Concentration: 0.2mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNUB1276-500 | Biotium | 500uL | 549.6 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275), Concentration: 0.2mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNCH1276-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNCH1276-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC881276-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC881276-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF488A conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNCB1276-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNCB1276-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),Biotin conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC611276-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC611276-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF660R conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC681276-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF568 conjugate, Concentration: 0.1mg/mL |
|||
Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275) Antibody |
|||
BNC681276-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Cytokeratin 10 (Suprabasal Epithelial Marker) (KRT10/844 + KRT10/1275),CF568 conjugate, Concentration: 0.1mg/mL |